Huons Group said on the 6th it will push a new business that uses artificial intelligence (AI) to diagnose skin. Humedix and Huons Meditech signed a three-party business agreement with V&Co for this.
V&Co has a skin-diagnosis device called "Scena." Scena analyzes collagen density and the fascia layer with ultrasound and provides related data with AI. Huons Group expects to offer skin consultations with Scena at hospitals and expand opportunities for procedures.
The corporations plan to conduct joint marketing, such as medical staff academic activities. They will develop an algorithm that recommends personalized procedures using skin-diagnosis data. Choi Won-seok, CEO of V&Co, said, "The paradigm of skin diagnosis is shifting from experience to data."
Ha Chang-woo, CEO of Huons Meditech, said, "We plan to launch Scena in overseas markets." Kang Min-jong, CEO of Humedix, explained, "We will seek new business opportunities, including developing linked products."